2Darnell R, Posner J. Paraneoplastic syndromes involving the nervous system. N Engl J Med,2003,349:1543 - 1554.
3Graus F, Dalmau JO. Management of paraneoplastic neurological syndromes//Wiley RG. Neurological complications of cancer. New York: Marcel Dekker, 1995:167-198.
4Dalmau J, Rosenfeld MR. Paraneoplastic syndromes of the CNS. Lancet Neurol, 2008, 7: 327-340.
5Candler PM, Hart PE, Barnett M, et al. A follow up study of patients with paraneoplastic neurological disease in the United Kingdom. J Neurol Neurosurg Psychiatry, 2004, 75: 1411-1415.
6Schneider J. Tumor markers in detection of lung cancer. Adv Clin Chem, 2006, 42: 1-41.
7Basu S, Alavi A. Role of FDG-PET in the clinical management of paraneoplastic neurological syndrome: detection of the underlying malignancy and the brain PET-MRI correlates. Mol Imaging Biol, 2008,10:131-137.
8Shams 'ili S, Grefkens J, de Leeuw B, et al. Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients. Brain, 2003, 126:1409-1418.
9Graus F, Delattre JY, Antoine JC, et al. Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry, 2004, 75:1135-1140.
